Umbralisib, ublituximab and venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia

GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy?

FiTNEss: Investigating frailty-adjusted therapy in transplant non-eligible patients with NDMM

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results

Dasatinib vs imatinib for paediatric Ph ALL

Study of quadruple combination for induction resistant myeloma reveals novel immune checkpoints

KRd vs KTd followed by carfilzomib maintenance in newly diagnosed MM

Moxetumomab pasudotox-tdfk in heavily retreated r/r hairy cell leukaemia

Azacitidine plus nivolumab in older adults with AML or MDS

Venetoclax chemo combo active and well-tolerated in children with r/r AML

CARTITIUDE-1: BCMA-targeted CAR T-cell therapy shows high response rates in patients with multiple myeloma

CANDOR: Triple drug combo delays disease progression in stubborn multiple myeloma